You are here: Home > Institute of Excellence (CPD) > CPD Events > Macular Degeneration: A Cutting Edge Update on Wet & Dry MD including Latest Treatments & Trials

Macular Degeneration: A Cutting Edge Update on Wet & Dry MD including Latest Treatments & Trials

Date: 6/04/2022 (AEST)

Venue: Live Webinar- Online Delivery

Provider: Strathfield Retina Clinic

Contact: James Wong, [E] rachelle.lupingna@strathfieldretina.com.au, [P] (02) 9746 3378

Learning Objectives

  • Identify characteristics of Geographic Atrophy and higher risk dry macular degeneration phenotypes
  • Understand recent trial data about future treatments for Non-neovascular Macular Degeneration
  • Identify subtypes of Neovascular Macular Degeneration including Polypoidal Choroidal Vasculopathy
  • Understand treatment options for Neovascular MD subtypes
  • Understand new trial options and data for Neovascular MD
  • Understand Real World Evidence based guidance for treatment of Neovascular MD

Max CPD hours awarded: 1.75

Session Information

Name
Geographic Atrophy, High Risk Dry MD Phenotypes & New Treatments
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Subtypes of Wet MD: Do we really need to identify them? New Treatment & Trials
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
Real-World Guidance of Wet MD: What we should learn
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.5